Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001747821-26-000008·Decheng Capital Management III (Cayman), LLC
Schedule 13G ownership disclosure
BEYONDSPRING INC
Ordinary Shares, par value $0.0001 per share · CUSIP: G10830100
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Decheng Capital Management III (Cayman), LLC
Shares: 1,448,293.00 · Class: 3.5%
- Decheng Capital China Life Sciences USD Fund III, L.P.
Shares: 1,448,293.00 · Class: 3.5%
- Decheng Capital China Life Sciences USD Fund II, L.P.
Shares: 1,617,409.00 · Class: 3.9%
- Decheng Capital Management II (Cayman), LLC
Shares: 1,617,409.00 · Class: 3.9%
- Decheng Capital Global Healthcare Fund (Master), LP
Shares: 0.00 · Class: 0.0%
- Decheng Capital Global Healthcare GP, LLC
Shares: Unavailable · Class: 0.0%
- Xiangmin Cui
Shares: 3,065,702.00 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001747821-26-000008
- Form type
- SCHEDULE 13G/A
- Filer
- Decheng Capital Management III (Cayman), LLC
- CIK
- CIK 1747821
- Filed
- Oct 29, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership